hemopure
Commercial- Indications
- Anemia, Blood loss
Company intelligence / Profile preview
Biopure
Woodinville, Washington, United Statesbiopureus.com ↗
- Ownership
- Private
- Employees
- ~119
- Development stage
- Commercial
01
Overview
Historical: Biopure Corporation developed two hemoglobin-based blood substitutes—Hemopure for humans and Oxyglobin for veterinary use. Hemopure was approved in South Africa and Russia but failed to gain FDA approval due to safety concerns. The company went bankrupt in 2009.
Current: BioPure, now a WMFTS brand, specializes in high-purity single-use fluid path components supporting cGMP-compliant manufacturing across global biotech/pharma industries.
- Therapeutic areas
- OtherHematology
- Modalities
- Hemoglobin-based oxygen carriers (HBOCs) as blood substitutesSingle-use fluid path components and connectors for bioprocessing; not directly therapeutic but enabling technology for biologics manufacturing
- Industry
- Chemicals & Materials
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
U.S. Navy collaboration on trauma applications with Hemopurevarious regulatory partnerships during clinical development phase.No major disclosed pharma partnerships—focuses on supplying manufacturers globally with single-use process solutions rather than direct R&D collaborations.
Beyond the preview
Go deeper on Biopure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biopure.